BeyondSpring Inc. (BYSI) vs IGC Pharma, Inc. (IGC)
BeyondSpring Inc. and IGC Pharma, Inc. are both Biotechnology companies. BeyondSpring Inc. and IGC Pharma, Inc. are of similar size ($29.8M and $29.1M). BeyondSpring Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs −91.5%). Across the 15 metrics below, BeyondSpring Inc. leads on 12 and IGC Pharma, Inc. on 3.
Valuation
Profitability
| Metric | BYSI | IGC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 32.33% | 65.16% |
| Operating margin | 0.00% | (912.44%) | 0.00% |
| Net margin | 0.00% | (795.46%) | 0.00% |
| Free cash flow margin | 0.00% | (516.53%) | 0.00% |
| Return on equity | 24.96% | (143.46%) | (57.72%) |
| Return on assets | (29.29%) | (100.44%) | (49.22%) |
| Return on invested capital | 0.00% | (91.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack